Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 30S subunit of the bacterial ribosome is the small component of the 70S ribosome found in prokaryotes, composed of 16S ribosomal RNA (about 1542 nucleotides long) and 20–21 ribosomal proteins (S1–S21)[1][5][8]. Its core functions are to bind mRNA and monitor the codon-anticodon pairing with tRNA, ensuring fidelity during translation[1][3][6]. This subunit is responsible for decoding the mRNA sequence and initiates protein synthesis by recognizing the Shine-Dalgarno sequence (ribosome binding site on mRNA)—guided mainly by the 16S rRNA[5]. Many antibiotics target the 30S subunit to inhibit bacterial protein biosynthesis, making it a key therapeutic target in infectious disease[1][3]. The subunit structure consists of a large RNA backbone with numerous globular proteins that stabilize and modulate its activity[8]. Because it is essential for bacterial survival and differs structurally from eukaryotic ribosomes, the 30S subunit is a classic target in antibiotic development and bacterial identification, but resistance mutability and possible off-target (mitochondrial) effects in humans are major clinical considerations[1][3][5].
Inhibition of protein synthesis by binding the 30S subunit and disrupting mRNA decoding or tRNA binding; Error induction during translation (e.g., streptomycin induces miscoding); Blockage of initiation complex formation or translocation
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 30S subunit of bacterial ribosome (30S subunit).